Peripheral T-Cell Lymphoma (PTCL)

Peripheral T-cell Lymphoma (PTCL) is a sub-type of non-Hodgkins lymphoma. It is an aggressive, high-grade type of cancer. It generally has a poor prognosis, but may respond better to treatment than indolent, low-grade lymphoma.

Incidence

Only 15% of non-Hodgkins lymphoma patients have a PTCL subtype, the disease is more common in adults than children. Because Peripheral T-cell Lymphoma is aggressive, treatment is imperative to quality of life and survival.

Treatment

Currently, the treatments available for PTCL are chemotherapy, radiotherapy, steroids, and bone marrow transplant. One treatment has been approved by the FDA for initial treatment of PTCL, although there currently is no gold-standard treatment for use in recurring PTCL.

Clinical Trials

Clinical trials for recurring PTCL should be seen as an treatment option for as they allow patients to receive treatment which have been established as safe for humans, but are still undergoing studies to see how well they work.

Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

Belinostat

Belinostat is one drug being offered in clinical trials for PTCL. Common side effects of belinostat therapy include fatigue, nausea and vomiting. However, it has shown no toxicity to patients’ bone marrow which is the biggest limitation in of other successful chemotherapy combinations.

More Articles

More Articles

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

Small lymphocytic lymphoma (SLL), is a type of non-Hodgkin lymphoma characterized by an excess of white blood cells in the...

Lymphoplasmacytic Lymphoma (LPL) is an indolent (slow growing) cancer that affects plasma cells. A plasma cell...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

The question of what the difference is between leukemia and lymphoma is a commonly asked question. We should start by saying that emerging...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

As one of two primary categories of lymphatic cancer, Hodgkin's lymphoma (HL) attacks the patient's white...

The diagnosis of a low grade B cell lymphoma is both a specific and a non-specific diagnosis that contains the following components:

What...

Hearing about lymphoma recurrence is about the least-welcome news a patient can hear. But what exactly does it mean?

To begin, lymphoma...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...